Replies to post #354241 on Amarin Corp Plc (AMRN)

[rafunrafun]

One slight correction in green

Generic Vascepa
TRx 17,511; +4.5% (+755) w/w; As % of total V: 17.7%
NRx 9,910; +2.5% (+238) w/w; As % of total V: 21.3%
Ref 7,601; +7.3% (+517) w/w; As % of total V: 14.5%

[ramfan60]

Thanks Raf....... total scripts are still under 100K.... interesting. I still think it's no accident that we are keeping a lid on this market.

[Number sleven]

Raf, Thanks for the numbers.
Sleven,

[Whalatane]

Raf. thx for the script data
Kiwi

[lizzy241]

raf, Thanks for posting scripts. At least we're not going down in numbers.

[rafunrafun]

Scripts for week ending September 10, 2021 - Labor Day week

Overall drug TRx are -7.3% w/w

Vascepa
TRx 75,570; -7.3% (-5,975) w/w; -11.8% y/y
NRx 32,640; -10.8% (-3,943) w/w; -15.9% y/y
Ref 42,930; -4.5% (-2,032) w/w; -8.4% y/y

Lovaza (Generic & Brand)
TRx 58,968; -7.0% (-4,453) w/w; -1.2% y/y
NRx 27,486; -10.1% (-3,085) w/w; -3.9% y/y
Ref 31,482; -4.2% (-1,368) w/w; +1.4% y/y

Generic Vascepa
TRx 17,227; -1.6% (-284) w/w; As % of total V: 18.6%
NRx 9,460; -4.5% (-450) w/w; As % of total V: 22.5%
Ref 7,768; +2.2% (+167) w/w; As % of total V: 15.3%

Generic Vascepa by Manufacturer
Hikma TRx 11,548 (-734); Generic share 67.0%; Total V share 12.4%
Reddy TRx 5,679 (+450); Generic share 33.0%; Total V share 6.1%